EMA Authorised: Neoclarityn (desloratadine) — Organon N.V.

View source ↗

Summary

The EMA authorised Neoclarityn (desloratadine) by Organon N.V. for allergic rhinitis (perennial and seasonal) and urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Neoclarityn (desloratadine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Organon N.V.. Decision date: 26/02/2026